6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 233/75 (2006.01) A61K 31/195 (2006.01) A61K 31/196 (2006.01) A61K 31/341 (2006.01) A61K 31/343 (2006.01) A61K 31/404 (2006.01) A61K 31/41 (2006.01) A61K 31/415 (2006.01) A61K 31/422 (2006.01) A61P 7/02 (2006.01) C07C 233/73 (2006.01) C07C 235/48 (2006.01) C07D 209/42 (2006.01) C07D 231/14 (2006.01) C07D 257/04 (2006.01) C07D 263/34 (2006.01) C07D 307/68 (2006.01) C07D 307/84 (2006.01) C07D 307/85 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 413/12 (2006.01)

Patent

CA 2450174

This invention provides novel compounds, pharmaceutical compositions and methods of treating thrombotic disorders in mammals, the compounds having the formula (I), wherein: Ar is phenyl, naphthyl, furanyl, benzofuranyl, indolyl, pyrazolyl, oxazolyl, fluorenyl, phenylcycloalkane where the cycloalkane can be cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl and Ar can be optionally substituted by one or more groups selected from C1-C6 alkyl, C1-C6 alkoxy, hydroxy, phenyl-(CH2)0-6-, phenyl-(CH2)0-6O-,C3-C6 cycloalkyl, -(CH2)-C3-C6 cycloalkyl, halogen, C1-C3 perflouroalkyl and C1-C3 perfluoroalkoxy where phenyl can be substituted with from one or more groups selected from C1-C6 alkyl, C1-C6 alkoxy, phenyl, halogen, trifluoromethyl and trifluoromethoxy; R1 is hydrogen, C1-C6 alkyl or phenyl-(CH2)1-6- where phenyl can be substituted with C1-C6 alkyl, C1-C6 alkoxy, halo, trifluoromethyl and trifluoromethoxy; R2 and R3 are H, C1-C6 alkyl, phenyl-(CH2)0-3-, halo and C1-C3 perfluoroalkyl where phenyl can be substituted with C1-C6 alkyl, C1-C6 alkoxy, halo, trifluoromethyl and trifluoromethoxy; R4 is -CHR5CO2H or -CH2-tetrazole where R5 is H or benzyl; and n = 0 or 1; or a pharmaceutically acceptable salt or ester form thereof.

L'invention porte: sur de nouveaux composés, sur des préparations pharmaceutiques et sur des procédés de traitement de troubles thrombotiques chez les mammifères. Lesdits composés présentent la formule (I) dans laquelle: Ar est phényle, naphthyle, furanyle, benzofuranyle, indolyle, pyrazolyle, oxazolyle, fluorényle, phénylcycloalcane où le cycloalcane peut être cyclopropyle, cyclobutyle, cyclopentyle ou cyclohéxyle et Ar peut être facultativement substitué par un ou plusieurs groupes sélectionnés parmi C¿1?-C¿6? alkyle, C¿1?-C¿6? alkoxy, hydroxy, phényl-(CH¿2?)¿0-6?-, phényl-(CH¿2?)¿0-6?O-,C¿3?-C¿6? cycloalkyle, -(CH¿2?)-C¿3?-C¿6? cycloalkyle, halogène, C¿1?-C¿3? perflouroalkyle et C¿1?-C¿3? perfluoroalkoxy phényle peut être substitué par un ou plusieurs groupes sélectionnés parmi C¿1?-C¿6? alkyle, C¿1?-C¿6? alkoxy, phényle, halogène, trifluorométhyle et trifluorométhoxy; R¿1? est hydrogène, C¿1?-C¿6? alkyle ou phényl-(CH¿2?)¿1-6?- où phényle peut être substitué par C¿1?-C¿6? alkyle, C¿1?-C¿6? alkoxy, halo, trifluorométhyle et trifluorométhoxy; R¿2? et R¿3? sont H, C¿1?-C¿6? alkyle, phényl-(CH¿2?)¿0-3?-, halo et C¿1?-C¿3? perfluoroalkyle où phényle peut être substitué par C¿1?-C¿6? alkyle, C¿1?-C¿6? alkoxy, halo, trifluorométhyle et trifluorométhoxy; R¿4? est -CHR¿5?CO¿2?H ou -CH¿2?-tétrazole où R¿5? est H ou benzyle; et n = 0 ou 1; ou un de leurs sels ou esters pharmacocompatibles.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1672727

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.